The global medicinal herbs market is projected to grow at a 4.4% CAGR from 2025 to 2035, supported by rising demand for natural health solutions and plant-based therapeutics.

November 7, 2026 The global medicinal herbs market is projected to increase from USD 6.4 billion in 2025 to USD 9.8 billion by 2035, according to Fact.MR. The market will register an absolute increase of USD 3.4 billion during the forecast period, representing total growth of 53.1% at a compound annual growth rate (CAGR) of 4.4%. Increasing consumer preference for natural remedies, wider acceptance of traditional medicine, and expanding nutraceutical applications are supporting this expansion.

The shift toward preventive healthcare is changing demand patterns. Consumers are increasingly considering plant-based alternatives for everyday wellness, immunity support, and health maintenance. Medicinal herbs are also finding wider applications in dietary supplements, functional foods, cosmetics, and modern healthcare formulations.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=4070

Medicinal Herbs Market Growth Driven by Natural Healthcare Demand

The growing interest in holistic wellness is creating new opportunities for medicinal herb manufacturers. Traditional medicine systems, including Ayurveda, Traditional Chinese Medicine, and Unani, continue to influence product development and consumer preferences. Their integration with modern healthcare is encouraging greater attention to standardized herbal formulations.

Herbs such as turmeric, ginseng, echinacea, and ashwagandha are gaining attention in nutraceutical formulations. Manufacturers are incorporating these ingredients into supplements, functional beverages, teas, and health shots. Their established associations with antioxidant activity, immune support, and adaptogenic properties are contributing to wider commercial applications.

The cosmetics industry is another area of expanding demand. Herbal extracts are increasingly used in skincare, haircare, and anti-aging formulations as brands respond to consumer interest in naturally positioned personal care products.

Whole Dried Herbs Retain Their Leading Product Position

Whole dried herbs are projected to account for 42.0% of the medicinal herbs market in 2025, making them the leading product segment. Their traditional acceptance and preservation of complete plant material continue to support demand among herbal medicine practitioners and consumers.

Whole dried herbs remain important for conventional preparation methods. They are used in different cultural healing practices, where consumers value authentic ingredients and familiar preparation techniques. Their established position also supports demand from manufacturers seeking recognizable botanical raw materials.

Herbal extracts and oils contribute to the market through more specialized applications. Advances in extraction and processing technologies are helping manufacturers develop standardized ingredients with consistent potency and improved formulation characteristics.

Nutraceuticals Account for 44.0% of Market Demand

The nutraceuticals segment is expected to hold a 44.0% share of the medicinal herbs market in 2025. Demand is supported by the increasing use of botanical ingredients in dietary supplements, functional foods, and products designed for preventive healthcare.

Manufacturers are investing in standardized herbal extracts and quality assurance processes to improve formulation consistency. Research into herbal medicine is also supporting product development, particularly where manufacturers seek more consistent ingredient specifications and better bioavailability.

Over-the-counter remedies represent another application area, while cosmetics and other personal care products provide additional avenues for botanical ingredient suppliers.

Medicinal Herbs Market: Forecast Highlights Through 2035

Fact.MR estimates that the market will reach USD 7.9 billion by 2030, adding USD 1.5 billion between 2025 and 2030. This represents 44.1% of the total forecast value increase.

The following five years are expected to contribute the remaining 55.9% of market expansion. Between 2030 and 2035, the market is projected to increase by another USD 1.9 billion, reaching USD 9.8 billion.

Standardized herbal extract production, innovative delivery systems, and personalized herbal medicine applications are expected to shape this later phase. Growing interest in evidence-based herbal products is also encouraging manufacturers to strengthen quality control and therapeutic validation processes.

USA Leads Country-Level Growth

The United States is projected to record the highest CAGR among the countries covered, at 4.9% between 2025 and 2035. Expanding natural health markets, greater acceptance of integrative medicine, and demand for plant-based therapeutics are supporting this outlook.

Mexico follows with a projected CAGR of 4.6%, supported by traditional medicine heritage, medicinal plant biodiversity, and expanding commercial cultivation.

Germany is expected to register 4.2% growth, while France is forecast to expand at 4.0%. Both markets benefit from established herbal medicine traditions and an emphasis on product quality and scientific validation.

The United Kingdom is projected to record a 3.8% CAGR. South Korea and Japan are expected to grow at 3.6% and 3.4%, respectively, supported by traditional medicine practices and demand for quality herbal preparations.

Europe's medicinal herbs market is forecast to increase from USD 1.8 billion in 2025 to USD 2.7 billion by 2035, representing a CAGR of 4.1%.

Quality Standardization and Sustainable Cultivation Shape Competition

The medicinal herbs market faces challenges related to inconsistent raw material quality, regulatory differences, and the sustainability of wild harvesting. These issues are encouraging producers to strengthen cultivation practices, processing capabilities, and supply chain traceability.

Martin Bauer Group leads the competitive landscape with a 7.2% market share. Its activities include botanical sourcing, cultivation partnerships, extraction capabilities, and quality control systems.

Other established participants include Naturex, Nexira, Starwest Botanicals, Indena, and Givaudan. These companies participate across botanical ingredients, herbal extracts, and specialized plant-based applications.

Martin Bauer Group is a botanical ingredient supplier that provides medicinal herb solutions across therapeutic and commercial applications.

Investment in sustainable cultivation and advanced extraction methods is expected to remain important as manufacturers respond to growing requirements for consistent ingredients and traceable sourcing.

Outlook for the Medicinal Herbs Market

The medicinal herbs market is positioned for continued expansion through 2035. Its projected increase to USD 9.8 billion reflects growing consumer interest in natural health solutions and the broader commercial use of botanical ingredients.

For manufacturers, product standardization and sustainable sourcing will remain important considerations. Expanding nutraceutical demand and the integration of traditional medicine with modern healthcare are also expected to influence future product development.

About Fact.MR

Fact.MR is a market research and consulting firm providing market intelligence, industry analysis, and strategic insights across multiple sectors. The company delivers research covering market size, growth forecasts, competitive landscapes, emerging trends, and industry developments to support informed business decisions.